S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes

Brinks, Henriette; Rohde, David; Voelkers, Mirko; Qiu, Gang; Pleger, Sven T; Herzog, Nicole; Rabinowitz, Joseph; Ruhparwar, Arjang; Silvestry, Scott; Lerchenmüller, Carolin; Mather, Paul J; Eckhart, Andrea D; Katus, Hugo A; Carrel, Thierry; Koch, Walter J; Most, Patrick (2011). S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. Journal of the American College of Cardiology, 58(9), pp. 966-73. New York, N.Y.: Elsevier 10.1016/j.jacc.2011.03.054

Full text not available from this repository. (Request a copy)

This study investigated the hypothesis whether S100A1 gene therapy can improve pathological key features in human failing ventricular cardiomyocytes (HFCMs).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiovascular Surgery

UniBE Contributor:

Most, Henriette and Carrel, Thierry

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0735-1097

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:20

Last Modified:

17 Dec 2014 07:33

Publisher DOI:

10.1016/j.jacc.2011.03.054

PubMed ID:

21851887

Web of Science ID:

000293947100014

URI:

https://boris.unibe.ch/id/eprint/6601 (FactScience: 211597)

Actions (login required)

Edit item Edit item
Provide Feedback